SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The company witnessed a 21.46% growth in the revenue at Rs. 5869.69 millions for the quarter ended September 2022 as compared to Rs. 4832.63 millions during the year-ago period.Profit after Tax for the quarter ended September 2022 saw a decline of -60.80% from Rs. 216.98 millions to Rs. 85.05  millions.Operating profit for the quarter ended September 2022 decreased to 717.20 millions as compared to 914.88 millions of corresponding quarter ended September 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 5869.69 4832.63 21.46 11670.95 10038.78 16.26 29464.36 20326.20 44.96
Other Income 330.38 119.32 176.89 525.66 508.20 3.44 484.09 809.20 -40.18
PBIDT 717.20 914.88 -21.61 934.37 2285.93 -59.13 6393.56 4570.66 39.88
Interest 2.99 3.48 -14.08 9.43 7.61 23.92 16.27 19.90 -18.24
PBDT 714.21 911.40 -21.64 924.94 2278.32 -59.40 6377.29 4550.76 40.14
Depreciation 603.91 606.28 -0.39 1151.12 1145.37 0.50 2452.93 1703.93 43.96
PBT 110.30 305.12 -63.85 -226.18 1132.95 -119.96 3924.36 2846.83 37.85
TAX 25.25 88.14 -71.35 -55.93 360.99 -115.49 1095.45 748.89 46.28
Deferred Tax 25.25 12.23 106.46 -55.93 84.00 -166.58 359.15 235.31 52.63
PAT 85.05 216.98 -60.80 -170.25 771.96 -122.05 2828.91 2097.94 34.84
Equity 902.21 902.21 0.00 902.21 902.21 0.00 902.20 902.20 0.00
PBIDTM(%) 12.22 18.93 -35.46 8.01 22.77 -64.84 21.70 22.49 -3.50

Sharda Cropchem Share Price

1109.75 -47.65 (-4.12%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 642.30
PI Industries 3068.35
Bayer CropScience 4742.40
Sharda Cropchem 1109.75
Sumitomo Chemical 446.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×